Buscador de publicaciones

Publicaciones

  • Cubiró X, Garcia-Melendo C, Morales-Munera CE, Roé-Crespo E, Riera-Mestre A, Mora-Luján JM, Iriarte A, Puig L and Baselga E.

    Satisfactory treatment of mucocutaneous lesions in hereditary hemorrhagic telangiectasia patients with dual pulsed dye laser and neodymium: yttrium-aluminum-garnet

    DERMATOLOGIC THERAPY . 34(6): . Nº de citas: 3

    [doi:10.1111/dth.15124]

  • Puttgen, KB, Hansen, LM, Lauren, C, Stefanko, N, Mathes, E, Olsen, GM, Tollefson, MM, Adams, D, Baselga E, Chamlin, S, Corey, K, Frascari, FF, Frieden, IJ, Galligan, ER, Gupta, D, Haggstrom, A, Horii, K, Hornik, CP, Klajn, J, Liberman, L, Mancini, A, Mannschreck, D, McGinness, A, McCuaig, C, Newell, B, Nguyen, H, Nopper, A, Oyesanya, T, Powell, J, Reynolds, M, Rios, M, Siegel, DH, Ward, K, Garzon, MC, Frommelt, P and Drolet, BA.

    Limited utility of repeated vital sign monitoring during initiation of oral propranolol for complicated infantile hemangioma

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY . 85(2): 345-352. Nº de citas: 17

    [doi:10.1016/j.jaad.2020.04.013]

  • Muñoz-Garza FZ, Ríos M, Roé-Crespo E, Bernabeu-Wittel J, Montserrat-García MT, Puig L, Gich I and Baselga E.

    Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage A Randomized Clinical Trial

    JAMA DERMATOLOGY . 157(5): 583-587. Nº de citas: 32

    [doi:10.1001/jamadermatol.2021.0596]

  • Rössler J, Baselga E, Davila V, Celis-Passini V, Diociaiuti A, El Hachem M, Mestre S, Haeberli D, Prokop A, Hanke C, Loichinger W, Quéré I, Baumgartner I, Niemeyer CM and Kapp FG.

    Severe adverse events during sirolimus "off-label" therapy for vascular anomalies

    PEDIATRIC BLOOD & CANCER . 68(8): . Nº de citas: 30

    [doi:10.1002/pbc.28936]

  • López-Sánchez C, Falla LM, Roé-Crespo E, Arostegui-Gorospe JI, Mozos A, Bernal S, Iznardo H and Baselga E.

    Excellent response to secukinumab in an infant with severe generalized pustular psoriasis

    JOURNAL OF DERMATOLOGY . 48(6): 907-910. Nº de citas: 12

    [doi:10.1111/1346-8138.15673]

  • Galligan ER, Baselga E, Frieden IJ, Kittler NW, Lauren CT, Morel KD, McCuaig C, Pope E, Tollefson M, Tantuco K, Wargon O and Garzon MC.

    Characterization of vascular stains associated with high flow

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY . 84(3): 654-660. Nº de citas: 8

    [doi:10.1016/j.jaad.2020.06.985]

  • Dávila Osorio VL, Vicente-Villa MA, Baselga E, Salvador-Hernandez H, Cruz-Martínez O and Prat-Torres CS.

    Adverse cutaneous effects of mitogen-activated protein kinase inhibitors in children

    PEDIATRIC DERMATOLOGY . 38(2): 420-423. Nº de citas: 8

    [doi:10.1111/pde.14354]

  • Valdivielso-Ramos, M, Martin-Santiago, A, Azana, JM, Hernandez-Nunez, A, Vera, A, Perez, B, Tercedor, J, Feito, M, Vicente-Villa MA, Prat-Torres CS, Lopez-Gutierrez, JC, Garnacho, G, Baselga E, Roe, E, Palencia, S, Cordero, P, Moreno, R, Agudo, A, de la Cueva, P and Torrelo, A.

    Capillary malformation-arteriovenous malformation syndrome: a multicentre study

    CLINICAL AND EXPERIMENTAL DERMATOLOGY . 46(2): 300-305. Nº de citas: 28

    [doi:10.1111/ced.14428]

  • Iznardo H, Baselga E, Mozos A, Szafranska J, Orellana-Fernández R and Roé E.

    Net-like superficial lymphatic malformation

    PEDIATRIC DERMATOLOGY . 38(2): 516-517. Nº de citas: 2

    [doi:10.1111/pde.14526]

  • Diociaiuti A, Carnevale C, Baselga E, Léauté-Labrèze C, Neri I, Rotunno R, Figà-Talamanca L and El Hachem M.

    Cutaneous Infantile Haemangiomas with Intracranial and Intraspinal Involvement: A European Multicentre Experience and Review

    ACTA DERMATO-VENEREOLOGICA . 100: . Nº de citas: 5

    [doi:10.2340/00015555-3608]